MNPR
NASDAQ HealthcareMonopar Therapeutics Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $57.60 |
|---|---|
| Volume | 105,097 |
| Market Cap | 384.92M |
| Beta | 1.670 |
| RSI (14-Day) | 56.4 |
| 200-Day MA | $59.23 |
| 50-Day MA | $61.51 |
| 52-Week High | $105.00 |
| 52-Week Low | $26.05 |
| Forward P/E | -16.54 |
| Price / Book | 2.71 |
🎯 Investment Strategy Scores
How MNPR scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
10/100
High dividend yield + low volatility
🚀 Moon Shot
68/100
High growth potential (high beta + oversold)
🔪 Falling Knife
30/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
82/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
9/100
Large-cap, institutional-quality stocks
Find MNPR in your text
Paste any text on the homepage — the tool will extract MNPR and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.